Wednesday 25 November at 1.00 pm
"Getting new drugs into the clinic: different perspectives"
This will be a full programme examining the problems of access to new treatment opportunities and we will have a distinguished panel of four speakers:
Our keynote speaker will be Prof. Bloor, who be giving a clinician's overview of the problems and successes of getting new treatments into the clinic.
We will also hear from:
Patient perspective: Robin Edwards
Pharma Company perspective: Dominic Pivonka, (Head of Health Technology Assessments and Pricing, AbbVie Ltd)
NHS and NICE perspective: Rob Coster, (National Programme of Care Manager - Blood and Infection, Specialised commissioning, NHS England)
We will start p romptly at 13:00, and you can join from 12:45. The Webinar will close by 14:30, allowing time for questions with the panellists
Please register by emailing: email@example.com
Questions in advance of the day can be submitted when you register.
The access code and password will be emailed to you after you register, usually within 24-48 hours. If you do not see the link please check your junk/spam mail box, if the link is not there please email firstname.lastname@example.org
This will be a full and interesting programme, and demand for places for previous webinars has been very high, so to help us to plan, please register your interest as soon as possible.
*We will also be streaming the webinar live on Facebook*. for which registration will not be required.
We look forward to welcoming you!
Best wishes, CLL Support Trustees.